Literature DB >> 30173352

Oocyte retrieval after heterotopic transplantation of ovarian tissue cryopreserved by closed vitrification protocol.

Yodo Sugishita1, Naoki Okamoto1, Atsushi Uekawa1, Takayuki Yamochi2, Mariko Nakajima1, Chie Namba1, Suguru Igarashi1, Takumi Sato1, Sei Ohta3, Makoto Takenoshita3, Shu Hashimoto2, Akiko Tozawa4, Yoshiharu Morimoto5, Nao Suzuki6.   

Abstract

PURPOSE: A device for closed vitrification was designed to reduce the risk of contamination and investigated on its efficacy for ovarian function recovery after cryopreservation and heterotopic transplantation.
METHODS: Ovarian tissues from green fluorescence protein transgenic mice (10 GFP mice) were vitrified using the device, and warmed ovarian tissues were transplanted into the ovarian bursa region in wild-type female mice (6 mice). Fresh ovarian tissues were similarly transplanted as a control. After recovery of the estrous cycle, mice were mated with male mice. Ovarian tissues from six cynomolgus monkeys were vitrified and warmed with the device for autologous, heterotopic transplantation. Fresh tissue transplantation was not performed for the control. Ovarian function was examined by recovery of the hormonal cycle. Histological examination was conducted.
RESULTS: The number of live pups per recipient mouse was not significantly different after transplantation of fresh or vitrified-warmed ovarian tissue, although the pregnancy rate was reduced with vitrified tissues. The hormonal cycle was restored in 5/6 monkeys after heterotopic transplantation of vitrified-warmed ovarian tissue. Follicles were harvested at eight sites in the omentum and 13 sites in the mesosalpinx. In vitro maturation (IVM)/IVF produced embryo but did not develop.
CONCLUSIONS: Resumption of the hormonal cycles, follicle development, and oocyte retrieval from vitrified-warmed ovarian tissue transplants may indicate that the use of vitrification for ovarian tissue in a closed system has a potential of clinical application without the risk of contaminations. More detailed analyses of the effects of vitrification on ovarian tissue, such as gene expression patterns in oocytes and granulosa cells, may be needed for establishing a standard procedure for cryopreservation of ovarian tissues in human.

Entities:  

Keywords:  Autologous transplantation; Closed device; Cynomolgus monkey; Fertility preservation; Ovarian tissue cryopreservation; Vitrification

Mesh:

Substances:

Year:  2018        PMID: 30173352      PMCID: PMC6240541          DOI: 10.1007/s10815-018-1298-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  24 in total

Review 1.  Risk of contamination of germplasm during cryopreservation and cryobanking in IVF units.

Authors:  A Bielanski; G Vajta
Journal:  Hum Reprod       Date:  2009-06-26       Impact factor: 6.918

Review 2.  Vitrification as an alternative means of cryopreserving ovarian tissue.

Authors:  Christiani A Amorim; Mara Curaba; Anne Van Langendonckt; Marie-Madeleine Dolmans; Jacques Donnez
Journal:  Reprod Biomed Online       Date:  2011-05-07       Impact factor: 3.828

3.  Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.

Authors:  Nao Suzuki; Nobuhito Yoshioka; Seido Takae; Yodo Sugishita; Midori Tamura; Shu Hashimoto; Yoshiharu Morimoto; Kazuhiro Kawamura
Journal:  Hum Reprod       Date:  2015-01-06       Impact factor: 6.918

Review 4.  Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications.

Authors:  M G Da Broi; V S I Giorgi; F Wang; D L Keefe; D Albertini; P A Navarro
Journal:  J Assist Reprod Genet       Date:  2018-03-02       Impact factor: 3.412

5.  Effects of vitrification solutions and equilibration times on the morphology of cynomolgus ovarian tissues.

Authors:  Shu Hashimoto; Nao Suzuki; Masaya Yamanaka; Yoshihiko Hosoi; Bunpei Ishizuka; Yoshiharu Morimoto
Journal:  Reprod Biomed Online       Date:  2010-10       Impact factor: 3.828

6.  Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue.

Authors:  Victoria Keros; Susanna Xella; Kjell Hultenby; Karin Pettersson; Maryam Sheikhi; Annibale Volpe; Julius Hreinsson; Outi Hovatta
Journal:  Hum Reprod       Date:  2009-04-09       Impact factor: 6.918

7.  Successful vitrification of bovine and human ovarian tissue.

Authors:  Noriko Kagawa; Sherman Silber; Masashige Kuwayama
Journal:  Reprod Biomed Online       Date:  2009-04       Impact factor: 3.828

8.  Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2.

Authors:  Christine Wulff; Helen Wilson; Stanley J Wiegand; John S Rudge; Hamish M Fraser
Journal:  Endocrinology       Date:  2002-07       Impact factor: 4.736

9.  Novel needle immersed vitrification: a practical and convenient method with potential advantages in mouse and human ovarian tissue cryopreservation.

Authors:  Yan Wang; Zhun Xiao; Lei Li; Wei Fan; Shang-Wei Li
Journal:  Hum Reprod       Date:  2008-07-09       Impact factor: 6.918

10.  Cryopreservation of follicles in human ovarian cortical tissue. Comparison of serum and human serum albumin in the cryoprotectant solutions.

Authors:  Julius Hreinsson; Pu Zhang; Marja Liisa Swahn; Kjell Hultenby; Outi Hovatta
Journal:  Hum Reprod       Date:  2003-11       Impact factor: 6.918

View more
  2 in total

1.  Comparison of open and a novel closed vitrification system with slow freezing for human ovarian tissue cryopreservation.

Authors:  Yodo Sugishita; Enes Taylan; Tai Kawahara; Bunyad Shahmurzada; Nao Suzuki; Kutluk Oktay
Journal:  J Assist Reprod Genet       Date:  2021-08-16       Impact factor: 3.357

Review 2.  Current and Future Perspectives for Improving Ovarian Tissue Cryopreservation and Transplantation Outcomes for Cancer Patients.

Authors:  Sanghoon Lee; Sinan Ozkavukcu; Seung-Yup Ku
Journal:  Reprod Sci       Date:  2021-03-31       Impact factor: 3.060

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.